HIV Infection Medications

300/150mg

Formulated to target HIV replication and indicated to support management of viral load in patients.

600 · 800mg

developed to target human immunodeficiency virus infection to support immune system health.

50mg

indicated to support viral load reduction in patients with human immunodeficiency virus infection, to target viral replication.

200 · 600mg

developed to manage hiv-1 infection indicated to target viral replication.

150mg

Developed to manage hiv infection and chronic hepatitis b to support long-term viral suppression.

400mg

developed to target human immunodeficiency virus infection to alleviate viral load.

200/50mg

Developed to manage HIV and indicated to target the replication of the virus in the body, supporting immune system health.

200 · 600mg

Formulated to address human immunodeficiency virus infection, developed to mitigate viral replication and support immune health within established treatment regimens.

300mg

indicated to mitigate viral replication to support immune system health in chronic infection.

300/200mg

intended to relieve viral replication in human immunodeficiency virus infection to support immune stability.

50mg

indicated for human immunodeficiency virus infection to alleviate viral load.

600/50/300mg

indicated for HIV infection to support viral suppression.

400mg

developed to target viral replication to support immune function.

200mg

Viramune is designed to target HIV to mitigate viral replication, utilized to support immune system function and to address long-term viral progression.

50/300/300mg

Developed for human immunodeficiency virus infection indicated to support viral load suppression.

400mg

Indicated to target viral replication in HIV management formulated to mitigate disease progression.

300mg

Formulated to target HIV infection to support immune system health in combination with other treatments.